Related Experiment Video
Updated: Oct 3, 2025

In vitro Organoid Culture of Primary Mouse Colon Tumors
Published on: May 17, 2013
Type-2 cGMP-dependent protein kinase suppresses proliferation and carcinogenesis in the colon epithelium
Bianca N Islam1, Sarah K Sharman2, Yali Hou2
1Department of Internal Medicine, Case Western Reserve University, Cleveland, OH, USA.
Abstract:
A large body of evidence has demonstrated that cyclic-guanosine monophosphate (cGMP), signaling has anti-tumor effects that might be used for colon cancer prevention. The tumor-suppressive mechanism and the signaling components downstream of cGMP remain largely unknown. The present study has characterized the expression of cGMP-dependent protein kinases (PKG1, PKG2) in normal and cancerous tissue from human colon. PKG1 was detected in both normal and tumor tissue, where it localized exclusively to the lamina propria and stroma (respectively). In contrast, PKG2 localized specifically to the epithelium where its expression decreased markedly in tumors compared to matched normal tissue. Neither PKG isoform was detected at the RNA or protein level in established colon cancer cell lines. To test for a potential tumor-suppressor role of PKG2 in the colon epithelium, Prkg2 knockout (KO) mice were subjected to azoxymethane/dextran sulfate-sodium (AOM/DSS) treatment. PKG2 deficiency was associated with crypt hyperplasia (Ki67) and almost twice the number of polyps per mouse as wild-type (WT) siblings. In vitro culture of mouse colon epithelium as organoids confirmed that PKG2 was the only isoform expressed, and it was detected in both proliferating and differentiating epithelial compartments. Colon organoids derived from Prkg2 KO mice proliferated more rapidly and exhibited a reduced ability to differentiate compared to WT controls. Taken together our results highlight PKG2 as the central target of cGMP in the colon, where it suppresses carcinogenesis by controlling proliferation in an epithelial-cell intrinsic manner.
Insights
Cyclic-guanosine monophosphate (cGMP) signaling suppresses colon cancer. Protein kinase G2 (PKG2) is key, acting within epithelial cells to control proliferation and prevent tumor formation.
Area of Science:
- Oncology
- Molecular Biology
- Gastroenterology
Background:
- Cyclic-guanosine monophosphate (cGMP) signaling exhibits anti-tumor properties relevant to colon cancer prevention.
- The precise mechanisms and downstream effectors of cGMP's tumor-suppressive actions in the colon are not fully understood.
Purpose of the Study:
- To investigate the expression and function of cGMP-dependent protein kinases (PKG1 and PKG2) in human colon tissues and their role in colon carcinogenesis.
- To determine if PKG2 acts as a tumor suppressor in the colon epithelium.
Main Methods:
- Characterized PKG1 and PKG2 expression in normal and cancerous human colon tissues using immunohistochemistry.
- Utilized Prkg2 knockout (KO) mice and azoxymethane/dextran sulfate-sodium (AOM/DSS) treatment to assess PKG2's role in vivo.
- Established and analyzed colon organoids from wild-type (WT) and Prkg2 KO mice to study epithelial cell proliferation and differentiation.
Main Results:
- PKG1 localized to the stroma and lamina propria, while PKG2 was specifically found in the colon epithelium, with significantly decreased expression in tumors.
- Prkg2 KO mice exhibited increased susceptibility to AOM/DSS-induced tumors, characterized by crypt hyperplasia and a higher polyp burden compared to WT mice.
- Colon organoids from Prkg2 KO mice showed enhanced proliferation and impaired differentiation compared to WT controls, confirming PKG2's epithelial-cell intrinsic function.
Conclusions:
- PKG2 is the primary mediator of cGMP's anti-carcinogenic effects in the colon epithelium.
- PKG2 suppresses colon carcinogenesis by intrinsically regulating epithelial cell proliferation and differentiation.
- Targeting PKG2 may offer a novel strategy for colon cancer prevention and therapy.
Related Concept Videos
Abnormal Proliferation
Inhibition of Cdk Activity
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules

